Skip to content

Introduction of robot-assisted hysterectomy for uterine cancer

Introduction of robot-assisted hysterectomy for uterine cancer - robot-assisted hysterectomy for uterine cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053851
Enrollment
8
Registered
2024-03-13
Start date
2023-10-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cancer

Interventions

Robotic-Assisted Hysterectomy for uterine cancer

Sponsors

International University of Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Patients with a clinical diagnosis of uterine cancer and all of the following -The lesion must be confined to the uterine body and within 1/2 of myometrial invasion (FIGO stage IA). -Patients with endometrial carcinoma of the endometrial histology. -Patients with endometrial carcinoma of differentiated or moderately differentiated type by endometrial histology (2) Patients who have been fully informed of the treatment (surgery) and have given their consent (including consent for annual reporting to the Japan Society of Obstetrics and Gynecology, which is mandatory for the facility performing the surgery). (3) Patients with ECOG Performance Status 0-1 (4) Patients who can undergo general anesthesia (5) Patients who can undergo laparoscopic surgery

Exclusion criteria

Exclusion criteria: (1) Patients under 20 years of age and over 80 years of age (2) Patients whose judgment ability seems to be inadequate. (3) Patients for whom vaginal retrieval of the uterus is considered difficult by internal examination and diagnostic imaging. (4) Patients with severe adhesions (5) Patients with severe obesity (6) Patients with a history of abdominal surgery that is considered difficult to perform laparoscopically (7) Patients with abdominal aortic aneurysm (8) Patients with cerebrovascular disorder (subarachnoid hemorrhage, cerebral infarction, transient ischemic attack, etc.) (9) Patients with severe glaucoma (10) Women who are pregnant or may become pregnant (11) Patients who wish to preserve their fertility. (12) Patients with other serious complications that make this study (this procedure) difficult in the surgeon's judgment.

Design outcomes

Primary

MeasureTime frame
To evaluate the safety and efficacy of robot-assisted hysterectomy for uterine cancer

Countries

Japan

Contacts

Public ContactYoko Nagayoshi

International University of Health and Welfare, Mita Hospital Gynecologic Oncology Center / Gynecology

y-nagayoshi@iuhw.ac.jp0334518121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026